Biocompatible ocular implants
November 15, 2013. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesOcular drug delivery device Ocular therapeutic system manufactured from copolymer Ocular therapeutic system with selected membranes for administering ophthalmic drug Selective administration of drug with ocular therapeutic system Ocular therapeutic system for dispensing a medication formulation Drug delivery system for controlled ocular therapy Method for treating intraocular malignancies Medication indicated for ocular hypertension Ocular insert housing steroid in two different therapeutic forms Biodegradable ocular implants InventorsAssigneeApplicationNo. 153184 filed on 11/15/1993US Classes:623/4.1, EYE PROSTHESIS (E.G., LENS OR CORNEAL IMPLANT, OR ARTIFICIAL EYE, ETC.)424/427, Ocular424/428Bioerrodable, resorbable, or dissolvingExaminersPrimary: Shay, Randy C.Attorney, Agent or FirmInternational ClassA61F 002/14AbstractImplants comprising active agents are employed for introduction into a suprachoroidal space or an avascular region of an eye for therapeutic purposes. The administration of drags is controlled and maintained for long periods of time, while ensuring the substantial absence of significant levels outside the site of administration.Other References
| |
